CHEK1 and neoplasm: In response to DNA damage, CHK1 inhibits the Cdc25 phosphatase, resulting in cyclin-dependent kinase (Cdk) inhibition and cell cycle arrest in the G2 phase mainly in p53 mutant tumor cells.